CollPlant Biotechnologies Ltd (CLGN, Financial) is set to release its Q3 2024 earnings on Nov 27, 2024. The consensus estimate for Q3 2024 revenue is $0.42 million, and the earnings are expected to come in at -$0.29 per share. The full year 2024's revenue is expected to be $1.69 million, and the earnings are expected to be -$1.26 per share. More detailed estimate data can be found on the Forecast page.
CollPlant Biotechnologies Ltd (CLGN, Financial) Estimates Trends
Revenue estimates for CollPlant Biotechnologies Ltd (CLGN) have remained flat at $1.69 million for the full year 2024 and at $13.00 million for 2025 over the past 90 days. Similarly, earnings estimates have remained flat at -$1.26 per share for the full year 2024 and at -$0.40 per share for 2025 over the same period.
CollPlant Biotechnologies Ltd (CLGN, Financial) Reported History
In the previous quarter of 2024-06-30, CollPlant Biotechnologies Ltd's (CLGN) actual revenue was $0.25 million, which missed analysts' revenue expectations of $0.40 million by -37.75%. CollPlant Biotechnologies Ltd's (CLGN) actual earnings were -$0.37 per share, which missed analysts' earnings expectations of -$0.27 per share by -37.04%. After releasing the results, CollPlant Biotechnologies Ltd (CLGN) was down by -1.12% in one day.
CollPlant Biotechnologies Ltd (CLGN, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 2 analysts, the average target price for CollPlant Biotechnologies Ltd (CLGN) is $12.50 with a high estimate of $14.00 and a low estimate of $11.00. The average target implies an upside of 193.59% from the current price of $4.26.
Based on GuruFocus estimates, the estimated GF Value for CollPlant Biotechnologies Ltd (CLGN, Financial) in one year is $0.59, suggesting a downside of -86.14% from the current price of $4.26.
Based on the consensus recommendation from 2 brokerage firms, CollPlant Biotechnologies Ltd's (CLGN, Financial) average brokerage recommendation is currently 2.0, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
